Novel 3,4-dihydroquinolin-2(1H)-one derivatives as dual inhibitor targeting AKR1B1/ROS for treatment of diabetic complications: Design, synthesis and biological evaluation

Authors:

Abstract
No abstract available

This publication has 18 references indexed in Scilit: